Schedule 13G ownership disclosure
Kitov Pharmaceuticals Holdings Ltd.
Security class unavailable · CUSIP: 49803V107
Event date: 2020-05-06
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 8,333,334
- Percent of class
- 8.7200%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001535610-20-000094
- Form type
- SC 13G
- Filer
- PURPLE BIOTECH LTD.
- CIK
- CIK 1614744
- Filed
- May 06, 2020
- Reporting period
- May 06, 2020
- Description
- Schedule 13G beneficial ownership